(MedPage Today) -- The FDA approved a higher dose of the GLP-1 receptor agonist semaglutide for weight loss, dubbed Wegovy HD, the agency announced on Thursday. The once-weekly injectable will come in a 7.2-mg dose -- three times the strength...
Source
MedPage Today
Opens original article in a new tab
The Trump administration is counting on its drug pricing efforts to help with the midterm elections.
(MedPage Today) -- Artificial intelligence (AI) could potentially be used to safely exclude low-risk mammograms from radiologist review, according to results from a prospective noninferiority trial. When comparing standard double-blind reading...
(MedPage Today) -- Some physician practices are charging patients for prior authorization requests or requiring annual administrative fees for such requests and letters of medical necessity, among other services. In February, patients at one Washington...
(MedPage Today) -- Lately, Priscilla Brown has had to choose between properly managing her type 2 diabetes and affording other necessities, like gas in her car. Some days, she takes half or a third of her prescribed insulin dose -- just to stretch...